Literature DB >> 3540918

Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.

D Hollanders.   

Abstract

Fifty three patients with endoscopically proven duodenal ulceration have cooperated in a clinical trial to compare the ulcer healing effect of tripotassium dicitrato bismuthate (TDB) at standard dosage administered either twice or four times daily. No statistically significant difference has been found to exist between ulcer healing in the two groups at 4 weeks (72% and 67%, P = 0.944) or at 8 weeks (92% and 81%, P = 0.504) and it is concluded that twice daily TDB maintains the effectiveness of the drug and has advantages for patient compliance.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3540918      PMCID： PMC2418563          DOI： 10.1136/pgmj.62.723.19

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  6 in total

1.  Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.

Authors:  J Koo; J Ho; S K Lam; J Wong; G B Ong
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

2.  [Bismuth treatment and blood bismuth levels].

Authors:  P Hillemand; M Pallière; B Laquais; P Bouvet
Journal:  Sem Hop       Date:  1977-09

3.  Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.

Authors:  D R Shreeve; H J Klass; P E Jones
Journal:  Digestion       Date:  1983       Impact factor: 3.216

4.  Randomised open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer.

Authors:  G Vantrappen; P Rutgeerts; L Broeckaert; J Janssens
Journal:  Gut       Date:  1980-04       Impact factor: 23.059

5.  Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.

Authors:  D F Martin; D Hollanders; S J May; M M Ravenscroft; D E Tweedle; J P Miller
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

6.  Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. A double-blind double-dummy comparative study.

Authors:  M G Moshal; J M Spitaels; F Khan
Journal:  S Afr Med J       Date:  1981-09-12
  6 in total
  2 in total

1.  Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.

Authors:  T O'Riordan; E Mathai; E Tobin; D McKenna; C Keane; E Sweeney; C O'Morain
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 2.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.